Han, Seung Min
Kim, Kyung Min
Cho, Soo-Jin
Yang, Kwang Ik
Kim, Daeyoung
Yun, Chang-Ho
Chu, Min Kyung
Funding for this research was provided by:
The National Research Foundation of Korea (2019R1F1A1053841)
Article History
Received: 24 September 2020
Accepted: 15 January 2021
First Online: 28 January 2021
Competing interests
: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: SJC was involved as a site investigator of a multicentre trial sponsored by Otsuka Korea, Eli Lilly and Co., and Novartis; functioned as an advisory member for Teva; and received research support from the Hallym University Research Fund 2016 and a grant from the Korean Neurological Association (KNA-16-MI-09). MKC was a site investigator for a multi-centre trial sponsored by Otsuka Korea, Novartis, International AG, and Eli Lilly and Co. He functioned as an advisory member for Teva, and received lecture honoraria from Allergan Korea, Handok-Teva, and Yuyu Pharmaceutical Company over the past 24 months. He received grants from the Yonsei University College of Medicine (2018–32-0037) and National Research Foundation of Korea (2019R1F1A1053841). The other authors declare no conflict of interest.